Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models
Mei‐Juan Tu(University of California, Davis), Ai‐Ming Yu(University at Buffalo, State University of New York), Chao Jian(Wuhan University), Pui Yan Ho(Roswell Park Comprehensive Cancer Center), Richard J. Bold(WinnMed), Frank J. Gonzalez(National Cancer Institute), Edward Kim(University of California, Davis), Qian-Yu Zhang(University of California, Davis), Jing-Xin Qiu(Roswell Park Comprehensive Cancer Center), Huichang Bi(Southern Medical University)
Cited by 50
Related Papers
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
|Journal of Lipid Research|2007|595
A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.
|Journal of Clinical Investigation|1998|406
Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391
Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
|Carcinogenesis|2006|359
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
|British Journal of Cancer|2003|256